The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Abstract
The cytosine analogues 5‐azacytosine (azacytidine) and 2′‐deoxy‐5‐azacytidine (decitabine) are the currently most advanced drugs for epigenetic cancer therapies. These compounds function as DNA methyltransferase inhibitors and have shown substantial potency in reactivating epigenetically silenced tumor suppressor genes in vitro. However, it has been difficult to define the mode of action of these drugs in patients and it appears that clinical responses are influenced both by epigenetic alterations and by apoptosis induction. To maximize the clinical efficacy of azacytidine and decitabine it will be important to understand the molecular changes induced by these drugs. In this review, we examine the pharmacological properties of azanucleosides and their interactions with various cellular pathways. Because azacytidine and decitabine are prodrugs, an understanding of the cellular mechanisms mediating transmembrane transport and metabolic activation will be critically important for optimizing patient responses. We also discuss the mechanism of DNA methyltransferase inhibition and emphasize the need for the identification of predictive biomarkers for the further advancement of epigenetic therapies. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., & Jacob, S. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4727-4741.2005 · Cited by 431
RetractedEpigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Cancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
Kantarjian, H., Issa, J. J., Rosenfeld, C. S., Bennett, J. M., Albitar, M., DiPersio, J., Klimek, V., Slack, J., de Castro, C., Ravandi, F., et al. (2006) · Cancer · doi:10.1002/cncr.21792 · Cited by 1,530
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 1×
“Mouse models with strongly and permanently reduced DNA methylation levels have shown genetic amplification and insertional activation of oncogenic loci.(30,31) These events are probably linked to the epigenetic reactivation of mobile DNA elements and need to be monitored and minimized during demethylation therapy.”
BackgroundEpigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Kantarjian, H., Oki, Y., Garcia-Manero, G., Huang, X., O'Brien, S., Cortes, J., Faderl, S., Bueso-Ramos, C., Ravandi, F., Estrov, Z., et al. (2007) · Blood · doi:10.1182/blood-2006-05-021162 · Cited by 685
Mackey, J. R., Mani, R. S., Selner, M., Mowles, D., YOUNG, J., Belt, J. A., Crawford, C. R., & Cass, C. E. (1998) · PubMed · Cited by 599
Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine.
Santi, D. V., Norment, A., & Garrett, C. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6993 · Cited by 518
Daskalakis, M., Nguyen, T. T., Nguyen, C., Guldberg, P., Köhler, G., Wijermans, P., Jones, P. A., & Lübbert, M. (2002) · Blood · doi:10.1182/blood.v100.8.2957 · Cited by 514
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
Lyko, F., & Brown, R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji311 · Cited by 510
Self-citationGore, S. D., Baylin, S., Sugar, E., Carraway, H., Miller, C. B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J. E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0080 · Cited by 474
Spratlin, J., Sangha, R., Glubrecht, D., Dabbagh, L., Young, J. D., Dumontet, C., Cass, C., Lai, R., & Mackey, J. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0224 · Cited by 430
Soriano, A. O., Yang, H., Faderl, S., Estrov, Z., Giles, F., Ravandi, F., Cortes, J., Wierda, W. G., Ouzounian, S., Quezada, A., et al. (2007) · Blood · doi:10.1182/blood-2007-03-078576 · Cited by 390
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., & Lyko, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2821 · Cited by 385
Self-citationPalii, S. S., Van Emburgh, B. O., Sankpal, U. T., Brown, K. D., & Robertson, K. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01799-07 · Cited by 382
Recruitment of DNA methyltransferase I to DNA repair sites
Mortusewicz, O., Schermelleh, L., Walter, J., Cardoso, M. C., & Leonhardt, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501034102 · Cited by 380
Howard, G., Eiges, R., Gaudet, F., Jaenisch, R., & Eden, A. (2008) · Oncogene · doi:10.1038/sj.onc.1210631 · Cited by 343
5-Azacytidine, a new, highly effective cancerostatic
Šorm, F., Pískala, A., Čihák, A., & Veselý, J. (1964) · Experientia · doi:10.1007/bf02135399 · Cited by 286
Membrane Transporters and Channels
Huang, Y., Anderle, P., Bussey, K. J., Barbacioru, C., Shankavaram, U., Dai, Z., Reinhold, W. C., Papp, A., Weinstein, J. N., & Sadée, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3884 · Cited by 285
DNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia
Yang, A. S., Doshi, K. D., Choi, S.-W., Mason, J. B., Mannari, R. K., Gharybian, V., Luna, R., Rashid, A., Shen, L., Estecio, M. R. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2385 · Cited by 266
Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
Li, L. H., Olin, E. J., Buskirk, H. H., & REINEKE, L. M. (1970) · PubMed · Cited by 263
Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase
Chen, L., MacMillan, A. M., Chang, W., Ezaz-Nikpay, K., Lane, W. S., & Verdine, G. L. (1991) · Biochemistry · doi:10.1021/bi00110a002 · Cited by 249
Delivery of 5-Aza-2′-Deoxycytidine to Cells Using Oligodeoxynucleotides
Yoo, C. B., Jeong, S., Egger, G., Liang, G., Phiasivongsa, P., Tang, C., Redkar, S., & Jones, P. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0251 · Cited by 219
García-Manteiga, J. M., Molina‐Arcas, M., Casado, F. J., Mazo, A., & Pastor‐Anglada, M. (2003) · PubMed · Cited by 211
Chuang, J. C., Yoo, C. B., Kwan, J. M., Li, T. W. H., Liang, G., Yang, A. S., & Jones, P. A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0172 · Cited by 210
Role of the DNA Methyltransferase Variant DNMT3b3 in DNA Methylation
Weisenberger, D. J., Velicescu, M., Cheng, J. C., Gonzales, F. A., Liang, G., & Jones, P. A. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.62.2.1 · Cited by 183
Phosphorylation of Uridine and Cytidine Nucleoside Analogs by Two Human Uridine-Cytidine Kinases
Van Rompay, A. R., Norda, A., Lindén, K., Johansson, M., & Karlsson, A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12578-3 · Cited by 182
Hubeek, I., Stam, R. W., Peters, G. J., Broekhuizen, R., Meijerink, J. P. P., van Wering, E. R., Gibson, B. E. S., Creutzig, U., Zwaan, C. M., Cloos, J. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602881 · Cited by 150
Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands
Bender, C. M., Gonzalgo, M. L., Gonzales, F. A., Nguyen, C. T., Robertson, K. D., & Jones, P. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6690 · Cited by 142
Samlowski, W. E., Leachman, S. A., Wade, M. L., Cassidy, P. B., Porter-Gill, P. A., Busby, L. T., Wheeler, R. H., Boucher, K. M., Fitzpatrick, F. A., Jones, D. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.118 · Cited by 141
Capillary electrophoretic analysis of genomic DNA methylation levels
Stach, D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng002 · Cited by 140
Trapped in action: direct visualization of DNA methyltransferase activity in living cells
Schermelleh, L., Spada, F., Easwaran, H., Zolghadr, K., Margot, J. B., Cardoso, M. C., & Leonhardt, H. (2005) · Nature Methods · doi:10.1038/nmeth794 · Cited by 138
Cell entry and export of nucleoside analogues
Pastor‐Anglada, M., Cano‐Soldado, P., Molina‐Arcas, M., Lostao, M. P., Larráyoz, I. M., Martínez‐Picado, J., & Casado, F. J. (2004) · Virus Research · doi:10.1016/j.virusres.2004.11.005 · Cited by 136
Mund, C., Hackanson, B. W., Stresemann, C., Lübbert, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0695 · Cited by 112
Self-citationFludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
Molina‐Arcas, M., Bellosillo, B., Casado, F. J., Montserrat, E., Gil, J., Colomer, D., & Pastor‐Anglada, M. (2003) · Blood · doi:10.1182/blood-2002-07-2236 · Cited by 107
High-performance Liquid Chromatographic Analysis of Chemical Stability of 5-aza-2′-Deoxycytidine
Lin, K.-T., Momparlerm, R. L., & Rivard, G. E. (1981) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600701112 · Cited by 102
Eliopoulos, N., Cournoyer, D., & Momparler, R. L. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050832 · Cited by 94
Chabot, G. G., Bouchard, J., & Momparler, R. L. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90293-9 · Cited by 91
Marcé, S., Molina‐Arcas, M., Villamor, N., Casado, F. J., Campo, E., Pastor‐Anglada, M., & Colomer, D. (2006) · PubMed · Cited by 83
DNA Methylation in 5-Aza-2′-Deoxycytidine-Resistant Variants of C3H 10T1/2 C18 Cells
FLATAU, E., Gonzales, F. A., Michalowsky, L. A., & Jones, P. A. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.10.2098 · Cited by 80
Liu, Z., Marcucci, G., Byrd, J. C., Grever, M. R., Xiao, J. J., & Chan, K. K. (2006) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2423 · Cited by 80
Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2'-deoxycytidine in rabbits and dogs.
Chabot, G. G., Rivard, G. E., & Momparler, R. L. (1983) · PubMed · Cited by 77
Liu, Z., Liu, S., Xie, Z., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1156 · Cited by 72
Kinetics of phosphorylation of 5-aza-2′-deoxycytidine by deoxycytidine kinase
Richard, L., Momparler, & Derse, D. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90454-4 · Cited by 63
Zhao, M., Rudek, M. A., He, P., Hartke, C., Gore, S. D., Carducci, M. A., & Baker, S. D. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.09.012 · Cited by 43
Choi, S. H., Byun, H., Kwan, J. M., Issa, J. J., & Yang, A. S. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06707.x · Cited by 39
Oral decitabine reactivates expression of the methylated γ‐globin gene in Papio anubis
Lavelle, D., Chin, J., Vaitkus, K., Redkar, S., Phiasivongsa, P., Tang, C., Will, R., Hankewych, M., Roxas, B. P., Singh, M., et al. (2007) · American Journal of Hematology · doi:10.1002/ajh.21020 · Cited by 35
Stegmann, A. P. A., Honders, M. W., Willemze, R., & Landegent, J. E. (1995) · PubMed · Cited by 26
Cited by
Fenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
Lyko, F. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.80 · Cited by 1,467
Self-citationTargeting the epigenetic regulation of antitumour immunity
Hogg, S. J., Beavis, P. A., Dawson, M. A., & Johnstone, R. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0077-5 · Cited by 630
Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer
Parker, W. B. (2009) · Chemical Reviews · doi:10.1021/cr900028p · Cited by 622
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
Bejar, R., Lord, A., Stevenson, K., Bar-Natan, M., Pérez-Ladaga, A., Zaneveld, J., Wang, H., Caughey, B., Stojanov, P., Getz, G., et al. (2014) · Blood · doi:10.1182/blood-2014-06-582809 · Cited by 562
Metadata
- Authors
- Stresemann, C., & Lyko, F.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2008-04-24
- Volume
- 123
- Issue
- 1
- Pages
- 8-13
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2017394727
- Cited by
- 949
- References
- 51
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.